Form 4 for SRRK Scholar Rock Holding Corp
Accepted 2023-10-18 00:00:00 ET · period of report 2023-10-16 · accession 0001209191-23-053113 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2023-10-18 | 2023-10-16 | SRRK | AKKARAJU SRINIVAS | Dir, 10% | P - Purchase | $6.85 | +2.19M | 6.79M | +48% | +$15.00M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-10-16 | P | A | 2,189,781 | $6.85 | 6,788,609 | I By Samsara BioCapital, L.P. | — | — | (F1) Shares held by Samsara BioCapital LP ("Samsara LP"). The Reporting Person is a managing member of Samsara BioCapital GP, LLC, the general partner of Samsara LP. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. |